Skip to content

Validation of a thyroid malignancy risk calculator in a Portuguese cohort

Sep 2026 · Endocrine · Vol 91 · 0 citations · 34 references
Medicine

TL;DR

The thyroid malignancy calculator showed excellent discrimination but imperfect calibration in this selected surgical cohort, and Prospective validation and clinical-impact assessment in unselected populations are required before it is used to alter fine-needle aspiration decisions.

View source

Similar papers

Oct 2026

A nomogram for preoperative risk evaluation of Bethesda III thyroid nodules.

BACKGROUND Bethesda Category III thyroid nodules (AUS/FLUS) pose a diagnostic challenge due to their malignancy rate of 15-30%. This study aimed to develop and validate a preoperative nomogram combining ultrasonographic features and BRAF V600E mutation status to enhance individualized risk assessment. METHODS We anal...

Riying Liang, Yue Jie, Shan Xu et al. · 0 citations
Review Open access Sep 2026

TSH Levels Are Predictive of Malignancy in Preoperative Thyroid Nodules: Our Single-Center Experience

Objective: To evaluate the association between preoperative thyroid-stimulating hormone (TSH) levels and postoperative histopathological malignancy in patients undergoing thyroidectomy for thyroid nodules, and to compare the discriminative performance of TSH with that of TI-RADS.Material and Methods: A total of 366 pat...

F. Arıcı, Huseyin Ali Ozturk, Bektaş Işık et al. · 0 citations
Open access Sep 2026

Pattern of Thyroid Diseases Among Patients Undergoing Thyroidectomy: A Retrospective Study

Clinical warning symptoms combined with ultrasound findings improved preoperative risk stratification and may support earlier diagnosis and appropriate surgical management in resource-limited settings.

Hamdah A. ALomeri, Tareq Abdulwasee Noman · 0 citations
Open access Oct 2026

Comparison and Calibration of the 2025 and 2015 ATA Recurrence-Risk Classifications in Differentiated Thyroid Cancer

The 2025 American Thyroid Association (ATA) guidelines maintained the low- and high-risk categories and subdivided the intermediate-risk category of differentiated thyroid cancer (DTC) into low-intermediate and intermediate-high tiers. To determine whether observed rates of structural disease match the ris...

A. Alzahrani, Eman Albasri, A. Alkhamis et al. · 0 citations
Open access Oct 2026

Construction and validation of a nomogram based on inflammatory, nutritional and metabolic indicators for predicting the risk of papillary thyroid carcinoma

Objective To analyze the correlation between inflammation, nutrition and metabolic indicators and the risk of papillary thyroid carcinoma (PTC), and to construct and validate a nomogram for predicting PTC risk among patients with thyroid nodules undergoing surgery, to assist clinicians in making more individualized cli...

Zi-Yu Chen, Hang Su, Hong-Feng Wu et al. · 0 citations
Open access Oct 2026

Comparative Performance of the 2015 and 2025 American Thyroid Association Initial Recurrence Risk Stratification Systems in Differentiated Thyroid Cancer

Background: The 2025 American Thyroid Association (ATA) guidelines introduced significant modifications to the initial risk stratification system for differentiated thyroid cancer (DTC). However, the real-world prognostic performance and stage migration effects of these updates compared with the 2015 system remain unev...

Wei-Xun Ke, Xuan-Ling Zheng, Li-Ying Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.